Junctional Epidermolysis Bullosa Latest Advances
Find the Latest Research About Junctional Epidermolysis Bullosa
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 670 publications
A safer path to gene correction in junctional epidermolysis bullosa.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 15, 2025
Ophthalmic phenotype associated with a novel mutation in LAMB3 gene linked to uncommon Intermediate Junctional Epidermolysis Bullosa.
Journal: American journal of ophthalmology case reports
Published: August 30, 2025
Laryngo-Onycho-Cutaneous Syndrome Managed With Thalidomide.
Journal: Pediatric dermatology
Published: July 12, 2025
Junctional Epidermolysis Bullosa Caused by a Hemiallelic Nonsense Mutation in LAMA3 Revealed by 18q11.2 Microdeletion.
Journal: International journal of molecular sciences
Published: June 30, 2025
Ayurvedic management for Epidermolysis bullosa - A case report.
Journal: Journal of Ayurveda and integrative medicine
Published: May 02, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 25, 2025
Novel eRF3a degrader enhances gentamicin-induced premature termination codon readthrough in epidermolysis bullosa.
Journal: Molecular therapy. Nucleic acids
Published: March 18, 2025
Compound Heterozygous Null Variants in ITGB4 Gene Causing Severe Phenotype of Junctional Epidermolysis Bullosa With Pyloric Atresia in Thai Newborn: Genotype-Phenotype Correlation From a Case Report and Review of the Literature.
Journal: International journal of genomics
Published: February 21, 2025
The Spectrum of Epidermolysis Bullosa in KwaZulu-Natal, South Africa.
Journal: International journal of dermatology
Published: February 09, 2025
Last Updated: 02/24/2026